Aufa, S. and Ismy, J. (2026) “Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer”, Indonesian Journal of Global Health Research, 8(6), pp. 89–98. doi: 10.37287/ijghr.v8i6.2572.